7.00% p.a. Early Redemption Worst of GOAL

Underlying: GlaxoSmithKline / Novartis / Roche SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 52164275 / ISIN: CH0521642758

Last update 03.06.2020
  • Bid

    97.60 %
    Volume: 10'000

  • Ask

    98.60 %
    Volume: 10'000

CurrencyGBP
IssuerUBS AG, Jersey Branch
Settlementphysical
Fixing date02.03.2020
Expiry02.03.2022
Sideways return6.73% / 8.93% p.a.
Unit price1'000.00 GBP
Underlying price1)
GlaxoSmithKline
Novartis
Roche

16.64464 GBP
82.48 CHF
339.10 CHF
Display
  • Product chart
1) Prices are 15 Min. delayed